Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line

Cancer Letters

Volumn 126, Issue 2, 1998, Pages 187-192

  Mealey, Katrina L ^a   Barhoumi, Rola ^b   Rogers, Kenita ^b   Kochevar, Deborah T ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Canine; Doxorubicin; Multiple drug resistance; Osteosarcoma; P glycoprotein

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; VINCRISTINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOG; DRUG ACCUMULATION; DRUG CYTOTOXICITY; MULTIDRUG RESISTANCE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0031916871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00004-4     Document Type: Article

References (26)

1. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
2. Bradley G., Juranka P.F., Ling V. Mechanisms of multidrug resistance. Biochem. Biophys. Acta. 948:1988;87-128.
3. Goldstein L.J., Galski H., Fojo A., Willingham M., Lai S.-L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G.M., Lieber M., Cossman J., Gottesman M.M., Pastan I. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81:1989;116-124.
4. Bradley G., Ling V. P-Glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev. 13:1994;223-233.
5. LaRue S.M., Fox M.H., Withrow S.J., Powers B.E., Straw R.C., Cote I.M., Gillette E.L. Impact of heterogeneity in the predictive value of kinetic parameters in canine osteosarcoma. Cancer Res. 54:1994;3916-3921.
6. Brodey R.S. The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J. Biol. Med. 52:1979;345-361.
7. Kochevar D.T., Kochevar J., Garrett L. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model. Cancer Lett. 53:1990;213-222.
8. D.C. Dahlin, Osteosarcoma, in: D.C. Dahlin (Ed.), Bone Tumors, third edn., Charles C. Thomas, Springfield, IL, 1981, pp. 226-260.
9. Dorn D.R. Epidemiology of canine and feline tumors. J. Am. Anim. Hosp. Assoc. 12:1976;307-312.
10. Goorin A.M., Abelson H.T., Frei III E. Osteosarcoma: fifteen years later. N. Engl. J. Med. 313:1985;1637-1643.
11. Pylkanen L., Aho A.J., Ekfors T., Salmi T.T., Tuominen J., Viljanto J., Nikkanen V. Treatment results of osteogenic sarcoma. An evaluation of 36 patients treated during a 30-year period in south-western Finland. Eur. J. Surg. Oncol. 23:1997;54-58.
12. S.M. LaRue, S.J. Withrow, Tumors of the skeletal system, in: S.J. Withrow, E.G. MacEwen (Eds.), Clinical Veterinary Oncology, J.B. Lippincott, Philadelphia, PA, 1989, pp. 234-252.
13. Serra M., Scotlandi K., Manara M.C., Maurici D., Lollini P.-L., De Biovanni C., Toffoli G., Baldini N. Establishment and characterization of multidrug resistant human osteosarcoma cell lines. Anticancer Res. 13:1993;323-330.
14. Bodey B., Taylor C.R., Siegel S.E., Kaiser H.E. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Anticancer Res. 15:1995;2461-2468.
15. Serra M., Scotlandi K., Manara M., Maurici D., Benini S., Sarti M., Campanacci M., Baldini N. Analysis of P-glycoprotein expression in osteosarcoma. Eur. J. Cancer. 31A:1995;1009-2002.
16. Baldini N., Scotlandi K., Barbanti-Brodano G., Manara M.C., Maruici D., Bacci G., Bertoni F., Picci P., Sottili S., Campanacci M., Serra M. P-Glycoprotein expression and outcome in high-grade osteosarcoma. N. Engl. J. Med. 333:1995;1380-1385.
17. Yu G., Ahmad S., Aquino A., Fairchild C.R. Transfection with protein kinase C alpha confers increased multiple drug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 3:1991;181-189.
18. Chomczynski P., Sacchi N. Single method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
19. Lowry O. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Dalton W.S., Durie B.G., Alberts D.S., Gerlach J.H., Cress A.E. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Cancer Res. 46:1986;5125-5130.
21. Fuqua S.A., Moretti-Rojas I.M., Schneider S.L., McGuire W.L. P-Glycoprotein expression in human breast cancer cells. Cancer Res. 47:1987;2103-2106.
22. Gekeler V., Frese G., Diddens H., Probst H. Expression of a P-glycoprotein gene is inducible in a multidrug resistant human leukemia cell line. Biochem. Biophys. Res. Commun. 155:1988;754-760.
23. Roninson I.B., Chin J.E., Choi K., Gros P.et al. Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA. 83:1986;4538-4542.
24. Bhalla K., Hindenburg A., Taub R.N., Grant S. Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res. 45:1985;3657-3662.
25. McGown A.T., Murphy D., Crowther D., Fox B.W. Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy. Cancer Chemother. Pharmacol. 27:1991;413-415.
26. Michieli M., Damiani D., Michelutti A., Melli C., Russo D., Fanin R., Baccarani M. P170-dependent multidrug resistance: restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivatives. Haematologica. 79:1994;119-126.